AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3281704
Drug: HDM solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM solution applied daily to mildly eczematous or clinically uninvolved skin for 5 days.
Trial: 3281704
Drug: HDM solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM solution applied to normal, unabraded skin of prick test positive subjects without a history of dermatitis.
Trial: 3281704
Drug: Vehicle or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle or antigen solution applied to subjects negative on prick testing.
Trial: 20550022
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airway pressure (CPAP) treatment for 6 to 9 months
Trial: 9615962
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear treatment
Trial: 7805977
Drug: Syntometrine injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syntometrine injection
Trial: 2505960
Drug: Flumazenil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (30 mg oral dose)
Trial: 2505960
Drug: Flumazenil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (2 mg intravenous dose)
Trial: 1094320
Drug: Fludrocortisone, 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone, 0.1 mg twice daily
Trial: 17488411
Drug: GIK infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIK infusion (n = 14)
Trial: 12228778
Drug: Type I
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type I antiarrhythmic agents (secondary prevention after myocardial infarction)
Trial: 12228778
Drug: Alternative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative therapy (most often amiodarone)
Trial: 8578181
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole daily for 6 months
Trial: 8578181
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg omeprazole daily for 6 months
Trial: 8578181
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg omeprazole daily for 4-8 weeks
Trial: 2189929
Drug: Five-drug antiemetic
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-drug antiemetic regimen (metoclopramide, dexamethasone, diazepam, diphenhydramine, thiethylperazine)
Trial: 707580
Drug: Neither agent
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither agent (control group)
Trial: 31238061
Drug: Standard exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard exercise (e.g., treadmill, cycling)
Trial: 28784038
Drug: Pregabalin 50
RxNorm normalized name: pregabalin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 50 mg TDS for 3 days
Trial: 28784038
Drug: Acetaminophen 500
RxNorm normalized name: acetaminophen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 500 mg/6 h for 3 days
Trial: 23889722
Drug: Triple-combination treatment
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-combination treatment with olmesartan medoxomil (OM) 40 mg, amlodipine besylate (AML) 10 mg, and hydrochlorothiazide (HCTZ) 25 mg
Trial: 22030597
Drug: Triple-combination treatment
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-combination treatment
Trial: 22030597
Drug: Dual-combination treatments
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-combination treatments
Trial: 15054353
Drug: Low-fat dietary
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat dietary intervention (less than 20% energy from fat, five or more fruit/vegetable and six or more grain servings daily)
Trial: 11459901
Drug: 0.4 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g/kg/day IVIg for 3 days
Trial: 11459901
Drug: 0.4 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g/kg/day IVIg for 6 days
Trial: 9732070
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy (ZDV + ddC or ddI)
Trial: 9732070
Drug: Monotherapy (ZDV)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (ZDV)
Trial: 9732070
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with BVL <10,000 HIV-1 RNA copies/ml
Trial: 4051260
Drug: Papain (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Papain (1 mg/mL)
Trial: 29381568
Drug: Bupivacaine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (10 mL) via ultrasound-guided LFC nerve block technique
Trial: 22621316
Drug: Ongoing statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing statin + ezetimibe (simvastatin, atorvastatin or pravastatin + ezetimibe at doses of 20/10, 10/10 or 20/10 mg)
Trial: 22621316
Drug: Doubling the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doubling the dose of ongoing statin (simvastatin 40 mg, atorvastatin 20 mg or pravastatin 40 mg)
Trial: 19683989
Drug: Iloprost infusion
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost infusion initiated 5 days before surgery
Trial: 19683989
Drug: Diltiazem infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem infusion before removing the RA
Trial: 17603846
Drug: 10(6.7) focus‐forming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(6.7) focus‐forming units of the attenuated RIX4414 human rotavirus vaccine
Trial: 11524061
Drug: Felodipine-based regimen
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine-based regimen with additional antihypertensive drugs as needed
Trial: 8596135
Drug: rh‐GM‐CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rh‐GM‐CSF (5 micrograms/kg s.c. daily for 7 days)
Trial: 2198807
Drug: Trivalent virus
RxNorm normalized name: Influenza Trivalent Virus Vaccine (Types A and B)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent virus vaccine (measles AIK‐C strain, mumps Hoshino strain, rubella Takahashi strain)
Trial: 2198807
Drug: Monovalent measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent measles vaccine (AIK‐C strain)
Trial: 2198807
Drug: Monovalent mumps
RxNorm normalized name: mumps virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent mumps vaccine (Hoshino strain)
Trial: 7234826
Drug: Naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (750 mg/day)
Trial: 31184922
Drug: mDiab app
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: mDiab app with weekly coach calls for 12 weeks
Trial: 15331528
Drug: Insulin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (0.1 mU/kg body wt as bolus)
Trial: 11546713
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg x kg(‐1) urapidil
Trial: 11546713
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg x kg(‐1) urapidil
Trial: 11546713
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg x kg(‐1) urapidil
Trial: 9100580
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g glucose (Study 1)
Trial: 9100580
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g glucose (Study 2)
Trial: 7794122
Drug: Warfarin (2-7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (2-7 mg daily)
Trial: 2968309
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) infusion (125 ng/kg bolus followed by a 30-minute infusion at 25 ng/kg/min)
Trial: 26446709
Drug: Schema therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schema therapy (ST)
Trial: 29958220
Drug: Dexmedetomidine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.4 µg/kg IV bolus in 10 minutes, followed by 0.5-1.0 µg/kg/h)
Trial: 29958220
Drug: Remifentanil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.5 µg/kg IV bolus in 10 minutes, followed by 0.05-0.25 µg/kg/min)
Trial: 28370407
Drug: BPS804 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPS804 (5, 10, and 20 mg/kg, three escalating doses each separated by 2 weeks)
Trial: 19453322
Drug: i-gel supraglottic
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-gel supraglottic airway
Trial: 17078446
Drug: Acupuncture; specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture; specific dosage and duration not mentioned.
Trial: 15154919
Drug: Root canal
RxNorm normalized name: Canal + Gel 10% for Root Canal Preparation Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root canal treatment with one of three sealers chosen at random
Trial: 11316108
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol 2.5 mg with ipratropium 0.5 mg and placebo inhalers (MDI) with spacer
Trial: 11316108
Drug: Placebo nebules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nebules and inhaled salbutamol 400 microg with ipratropium 80 microg via MDI with spacer
Trial: 11316108
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol 400 microg with ipratropium 80 microg via MDI with spacer
Trial: 8513853
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg b.i.d. isradipine
Trial: 8513853
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of diclofenac and isradipine
Trial: 24189569
Drug: self-help version
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: self-help version of cognitive behavioral therapy (shCBT)
Trial: 21393063
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 1.5 g/day for 24 months
Trial: 17194233
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg.kg(‐1))
Trial: 12707479
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy plus routine care
Trial: 11028832
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg tropisetron
Trial: 2056905
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate (CC) 7.0 mg of anhydrous caffeine.kg‐1 body weight
Trial: 7171533
Drug: High-methoxyl pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-methoxyl pectin (15 g)
Trial: 7171533
Drug: Low-methoxyl pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-methoxyl pectin (15 g)
Trial: 28010246
Drug: Monovalent rAT
RxNorm normalized name: rat skin extract
DrugBank: Rattus norvegicus skin (DB10608)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent rAT or rLukS-PV dosages of 10, 25, 50, and 100 μg; bivalent rAT:rLukS dosages of 10:10, 25:25, and 50:50 μg; alum or saline placebo
Trial: 28010246
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg monovalent or bivalent rAT and rLukS-PV dose
Trial: 28010246
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of the vaccine
Trial: 24508897
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of tenofovir alafenamide
Trial: 24508897
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of tenofovir alafenamide
Trial: 24508897
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of tenofovir disoproxil fumarate
Trial: 15042669
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (paclitaxel followed by combined 5-fluorouracil, doxorubicin, and cyclophosphamide)
Trial: 11180038
Drug: Everolimus 0.5
RxNorm normalized name: everolimus 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and prednisone
Trial: 9621991
Drug: Antenatal corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal corticosteroid therapy (ACT) with dexamethasone
Trial: 9621991
Drug: Non-ACT group
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ACT group (no antenatal corticosteroid therapy)
Trial: 9621991
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment of the mother
Trial: 9621991
Drug: Tocolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocolytic treatment of the mother
Trial: 3357663
Drug: Intraumbilical oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraumbilical oxytocin (10 U diluted to 20 mL in normal saline)
Trial: 29102514
Drug: omalizumab 300
RxNorm normalized name: OMALIZUMAB 300MG/2ML INJ,SOLN,SYR,2ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omalizumab 300 mg
Trial: 27911016
Drug: omalizumab (75,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omalizumab (75, 150 or 300 mg)
Trial: 19090310
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of local anesthetic into the LITA tube
Trial: 12818462
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose hormone replacement therapy (LD‐HRT) with conjugated equine estrogens (CEE; 0.3 mg) and different progestins (2.5 mg medroxyprogesterone acetate, 5 mg dydrogesterone, 2.5 mg nomegestrol)
Trial: 10969300
Drug: Midazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.5 mg/kg) administered 5 min before surgery
Trial: 10969300
Drug: Midazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.5 mg/kg) administered 10 min before surgery
Trial: 10969300
Drug: Midazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.5 mg/kg) administered 20 min before surgery
Trial: 10969300
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered 15 min before surgery
Trial: 14621765
Drug: BT 563
RxNorm normalized name: BTS
DrugBank: Pyruvic acid (DB00119)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BT 563 (new monoclonal IL-2R antibody)
Trial: 26355978
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac (0.5 mg/kg) and acetaminophen (15 mg/kg)
Trial: 26355978
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (10 mg/kg) and acetaminophen (15 mg/kg)
Trial: 26355978
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen and acetaminophen
Trial: 8769685
Drug: Pravastatin sodium
RxNorm normalized name: Pravastatin Sodium
DrugBank: Pravastatin (DB00175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pravastatin sodium (10-15 mg/day for an average of 10.2 weeks)
Trial: 8769685
Drug: Simvastatin (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (5-10 mg/day for an average of 13.9 weeks)
Trial: 4073085
Drug: Ticarcillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticarcillin plus clavulanic acid (3 g every four hours)
Trial: 4073085
Drug: Clindamycin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin plus gentamicin (600 mg every six hours plus 3 to 5 mg/kg per day)
Trial: 30415816
Drug: Ixekizumab (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixekizumab (80 mg/2 weeks after 160-mg initial dose)
Trial: 26488229
Drug: 25 mL
RxNorm normalized name: ethanol 6.025 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mL hybrid palm oil daily for 3 months
Trial: 26488229
Drug: 25 mL
RxNorm normalized name: ethanol 6.025 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mL extra virgin olive oil daily for 3 months
Trial: 24536039
Drug: Barberry (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barberry (3 capsules daily for 6 weeks)
Trial: 24536039
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 capsules daily for 6 weeks)
Trial: 22821620
Drug: Epinephrine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (10 μg)
Trial: 31044424
Drug: Phenylephrine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine (100 μg)
Trial: 20051221
Drug: Armodafinil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil (200 mg once daily)
Trial: 12630074
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone and somatomedins
Trial: 7491886
Drug: Low-fat milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat milk (1.4 g Ca/d)
Trial: 7491886
Drug: Fermented low-fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented low-fat milk (1.4 g Ca/d)
Trial: 7491886
Drug: Soft drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft drink (0.16 g Ca/d)
Trial: 30699971
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g freeze-dried blueberry powder
Trial: 23551992
Drug: Partially hydrolysed
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolysed guar gum (PHGG), 10 g/d
Trial: 17870123
Drug: Alarm treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alarm treatment (controls, group E)
Trial: 12027843
Drug: Bain system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bain system + ACD with fresh gas flow 4.4‐6.4 l/min
Trial: 12027843
Drug: Low flow
RxNorm normalized name: high mallow flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low flow circle system with 1.5 l/min fresh gas flow
Trial: 7589007
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (Tissucol, 5 ml of 500 IU thrombin) applied in the area of axillary dissection
Trial: 7589007
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (Tissucol, 5 ml of 500 IU thrombin)
Trial: 1425713
Drug: Ciprofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (750 mg/12 h)
Trial: 21502621
Drug: Levofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (500 mg/12 h)
Trial: 21502621
Drug: Gatifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin (400 mg/24 h)
Trial: 21502621
Drug: Standard antituberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antituberculosis treatment alone (Control)
Trial: 15294406
Drug: Previously prepared
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previously prepared saline solutions
Trial: 15294406
Drug: Saline solutions
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solutions exposed for 24, 48, or 72 hours
Trial: 10395855
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccines (ACVs) - full strength, one-third strength, one-tenth strength
Trial: 10395855
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccines (ACVs)
Trial: 29145771
Drug: Simvastatin/chitosan gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin/chitosan gel (10 mg/mL) applied three times/day for 7 days
Trial: 29145771
Drug: Simvastatin suspension
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin suspension